| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |